September 25, 2019: Understanding the preventable burden of cancer in Canada: findings from the Canadian Population Attributable Risk of Cancer (ComPARe) study  

Speakers: Dr Christine Friedenreich (co-principal investigator), Dr Darren Brenner (co-principal investigator), Dr Leah Smith and Elizabeth Holmes 

The ComPARe study is the most comprehensive and up-to-date study on the preventable burden of cancer in Canada. Through the ComPARe study, we know that about 4 in 10 of all cancers in Canada can be prevented through healthy living and policies that protect the health of Canadians. The webinar provides an overview of the ComPARe study, methods, key findings and resources available.

 

About the ComPARe study

The Canadian Population Attributable Risk of Cancer (ComPARe) study estimates the number and percentage of cancer cases in Canada caused by preventable lifestyle, environmental and infectious agent risk factors. The ComPARe study also estimates how changes to these risk factors through prevention could affect the number of cancer cases in the future.